Male pattern baldness and its management: an update.

The document reviewed the management of androgenetic alopecia (AGA), also known as male pattern baldness, which affected up to 50% of males aged 30 to 50 years. It examined medical treatments like topical minoxidil, which was marketed for AGA, and other investigational drugs. Additionally, it discussed surgical approaches, including advancements in punch hair transplantation, alopecia reductions, and flap surgery.